A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
Milton S. Hershey Medical Center
Eli Lilly and Company
Eli Lilly and Company
UNICANCER
Mayo Clinic
Yonsei University
Taiho Pharmaceutical Co., Ltd.
Grupo Espanol de Investigacion en Sarcomas
Italian Sarcoma Group
Blokhin's Russian Cancer Research Center
Emory University
M.D. Anderson Cancer Center
Stanford University
St. Jude Children's Research Hospital
Sierra Oncology LLC - a GSK company
Children's Oncology Group
Innovent Biologics (Suzhou) Co. Ltd.
Roswell Park Cancer Institute
Peking University People's Hospital
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Eli Lilly and Company
Eleison Pharmaceuticals LLC.
Peking University People's Hospital
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
University of Miami
Alliance for Clinical Trials in Oncology
GOG Foundation
Memorial Sloan Kettering Cancer Center
NYU Langone Health
City of Hope Medical Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
University of Chicago
National Cancer Institute (NCI)
GOG Foundation
Memorial Sloan Kettering Cancer Center
GOG Foundation
GOG Foundation
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC